title: Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.
abstract: OBJECTIVE
  hDAB2IP is a candidate tumor suppressor gene. We studied the expression of its two variants, hDAB2IPA and hDAB2IPB, in normal tissues, and the expression and methylation status of hDAB2IPA in hepatocellular carcinomas (HCC) and cell lines.
  
  
  METHODS
  Conventional or real-time RT-PCR was performed in normal tissue samples, cell lines and HCC samples, and sequencing analysis and methylation-specific PCR in cell lines and HCC samples.
  
  
  RESULTS
  hDAB2IPA was the predominant isoform, being expressed in the majority of tissues examined. The expression of hDAB2IPA was silenced or down-regulated but could be restored by 5-aza-2'-deoxycytidine treatment in liver cancer cell lines. The reactivation of hDAB2IPA was associated with promoter demethylation. The correlation between promoter methylation and hDAB2IPA expression was confirmed in eight pairs of matched HCC samples. Further, the methylation of the hDAB2IPA promoter in HCC was confirmed in an additional 53 pairs of patient samples. More than 80% of HCC samples showed hDAB2IPA promoter methylation, compared to 11.5% in the corresponding adjacent normal tissue (p<0.0001, chi2).
  
  
  CONCLUSIONS
  Our data suggest that hDAB2IPA is the dominant isoform expressed in normal tissues. Its expression is suppressed in HCC, consistent with its role as a tumor suppressor gene, mainly by promoter methylation.
authors.affiliation: Department of Physiology, Faculty of Medicine, National University of Singapore, Block MD9, 2 Medical Drive, Singapore 117597, Singapore.
authors.forename: Guo-Hua
authors.initials: GH
authors.lastname: Qiu
authors.forename: Huangming
authors.initials: H
authors.lastname: Xie
authors.forename: Nicholas
authors.initials: N
authors.lastname: Wheelhouse
authors.forename: David
authors.initials: D
authors.lastname: Harrison
authors.forename: George G
authors.initials: GG
authors.lastname: Chen
authors.forename: Manuel
authors.initials: M
authors.lastname: Salto-Tellez
authors.forename: Paul
authors.initials: P
authors.lastname: Lai
authors.forename: James A
authors.initials: JA
authors.lastname: Ross
authors.forename: Shing Chuan
authors.initials: SC
authors.lastname: Hooi
mesh_terms: D000595:Amino Acid Sequence; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D019175:DNA Methylation; D015536:Down-Regulation; D005260:Female; D015870:Gene Expression; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009367:Neoplasm Staging; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000378:metabolism; D020703:ras GTPase-Activating Proteins / Q000378:metabolism*
chemical_list: C462952:DAB2IP protein, human; D020033:Protein Isoforms; D020703:ras GTPase-Activating Proteins